Clinical Trials
15 trialsNCT03556904 2026-01-15
FOcal Radiation for Oligometastatic Castration-rEsistant Prostate Cancer (FORCE)
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT02649829 2025-04-29
MESODEC
University Hospital, Antwerp
Phase 1/2 Completed
NCT04028479 2024-12-18
ROOT
Taproot Health
Completed
NCT03248570 2024-11-20
Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair Defects
University of California, San Francisco
Phase 2 Completed
NCT06531629 2024-08-06
Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
Peking University First Hospital
Completed
NCT03329950 2024-03-28
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Phase 1 Completed
NCT03410693 2022-09-28
FORT-1
Bayer
Phase 2/3 Completed
NCT05082818 2022-06-14
Outcome of Treating Bladder Cancer in Sohag University Hospital
Sohag University
Completed
NCT00002677 2019-11-04
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
University of Maryland, Baltimore
Phase 1 Completed
NCT03524391 2018-05-14
Effect of Yoga Counselling on Quality of Life and Psychological Outcomes of Prostate Cancer Patients
NMP Medical Research Institute
Phase NA Completed
NCT00006376 2013-12-04
R115777 in Treating Patients With Advanced Bladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005848 2013-07-11
R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
Fox Chase Cancer Center
Phase 2 Completed
NCT00002737 2012-07-11
Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00283062 2012-01-26
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy
Sanofi
Phase 3 Completed
NCT00108290 2008-04-04
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
VA Office of Research and Development
Phase 2 Completed